GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_283/2026

Gowling WLG v. Merz Therapeutics GmbH, Merz Pharmaceuticals LLC, Merz Pharma France-Viatris Santé

Datum
2026-02-19
Kammer
Paris (FR) Local Division
Verfahrensart
Application RoP262.1 (b)
Sprache
EN

Metadaten

Fall-IDUPC_CFI_283-2026-3c34f0fbb0a0
Aktenzeichen
RegisterzeichenUPC_CFI_283/2026
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 10

1 Paris Local Division UPC_CFI_283/2026 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 19/02/2026 concerning R. 262.1(b) Request for access to the case file - UPC_CFI_697/2025 APPLICANT Gowling WLG 38 avenue de l'Opera, 75002, Paris, FR Represented by Marianne SCHAFFNER PARTIES in the case UPC_CFI_697/2025 Merz Therapeutics GmbH Eckenheimer Landstraße 100 60318 Frankfurt am Main - DE Merz Pharmaceuticals LLC Unit 35/36, 6601 Six Forks Road, 4th Floor 27615 Raleigh, North Carolina - US 2 Merz Pharma France Tour EQHO, 2 Avenue Gambetta 92400 Courbevoie – FR Represented by Laëtitia Bénard PATENT AT ISSUE Patent no. Proprietor EP2377536 Merz Pharmaceuticals, LLC Patent no. SPC details EP2377536 SPC ID FR13C0033 National Designations FR Patent no. SPC I ...